EndoCure Overview
- Year Founded
-
2023
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
5
EndoCure General Information
Description
Developer of a diagnostic tool designed to allow the ailment to escalate into a severe, debilitating condition. The company offers a cutting-edge methodology encompassing a robotic scanning system with the standard transducer of an ultrasound device, achieving a seamless fusion of advanced technologies, enabling clients to identify and characterize the highlighted lesions, representing a transformative leap forward in not only the diagnosis and management of endometriosis but also in surgical planning.
Contact Information
Website
www.endocure.techCorporate Office
- 61 Haatzmaut street
- Haifi 3303331
- Israel
Corporate Office
- 61 Haatzmaut street
- Haifi 3303331
- Israel
EndoCure Timeline
EndoCure Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Accelerator/Incubator | 06-Mar-2024 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 01-Jan-2024 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 01-Jan-2024 | Completed | Generating Revenue | |||
| 2. Grant | 01-Jan-2024 | $1M | Completed | Generating Revenue | ||
| 1. Seed Round | 05-Dec-2023 | Completed | Generating Revenue |
EndoCure Patents
EndoCure Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026013597-A1 | Low-pressure-coupling ultrasound system | Pending | 09-Jul-2024 | ||
| AU-2024206423-A1 | Ultrasound system and method for selective diagnosis and treatment of pathogenic cells | Pending | 07-Jan-2023 | ||
| EP-4646151-A2 | Ultrasound system and method for selective diagnosis and treatment of pathogenic cells | Pending | 07-Jan-2023 | ||
| US-20250331806-A1 | Ultrasound system and method for selective diagnosis and treatment of pathogenic cells | Pending | 07-Jan-2023 | ||
| US-20250331813-A1 | Ultrasound system and method for selective diagnosis and treatment of pathogenic cells | Pending | 07-Jan-2023 | A61B8/085 |
EndoCure Signals
EndoCure Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| MassChallenge | Accelerator/Incubator | |||
| HiCenter | Accelerator/Incubator | Minority | ||
| Innovation Authority | Government | |||
| Tech4Eva | Accelerator/Incubator | |||
| Teuza | Venture Capital | Minority |
EndoCure FAQs
-
When was EndoCure founded?
EndoCure was founded in 2023.
-
Where is EndoCure headquartered?
EndoCure is headquartered in Haifi, Israel.
-
What is the size of EndoCure?
EndoCure has 10 total employees.
-
What industry is EndoCure in?
EndoCure’s primary industry is Diagnostic Equipment.
-
Is EndoCure a private or public company?
EndoCure is a Private company.
-
What is EndoCure’s current revenue?
The current revenue for EndoCure is .
-
Who are EndoCure’s investors?
MassChallenge, HiCenter, Innovation Authority, Tech4Eva, and Teuza have invested in EndoCure.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process